The Chemours Company (CC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.42	$0.42	0.0%	—	$1.6B	—
Q1 26	-$0.04	$0.05	+225.0%	—	$1.4B	—
Q4 25	$0.02	$0.05	+150.0%	—	$1.3B	—
Q3 25	$0.24	$0.2	-16.7%	—	$1.5B	—
Q2 25	$0.46	$0.58	+26.1%	—	$1.6B	—
Q1 25	$0.2	$0.13	-35.0%	—	$1.4B	—
Q4 24	$0.16	$0.11	-31.3%	—	$1.4B	—
Q3 24	$0.28	$0.4	+42.9%	—	$1.5B	—
Q2 24	$0.58	$0.38	-34.5%	—	$1.5B	—
Q1 24	$0.17	$0.32	+88.2%	—	$1.4B	—
Q4 23	$0.24	$0.31	+29.2%	—	$1.4B	—
Q3 23	$0.69	$0.63	-8.7%	—	$1.5B	—
Q2 23	$1.07	$1.1	+2.8%	—	$1.6B	—
Q1 23	$0.47	$0.98	+108.5%	—	$1.5B	—
Q3 22	$1.04	$1.24	+19.2%	—	$1.8B	—
Q2 22	$1.43	$1.89	+32.2%	—	$1.9B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$2.57	—	—	$5.8B	—
FY24	—	$0.58	—	—	$5.8B	—
FY23	—	-$1.6	—	—	$6B	—
FY22	—	$3.72	—	—	$6.8B	—
FY21	—	$3.69	—	—	$6.3B	—
FY20	—	$1.33	—	—	$5B	—
FY19	—	-$0.32	—	—	$5.5B	—
FY18	—	$5.62	—	—	$6.6B	—
FY17	—	$4.04	—	—	$6.2B	—
FY16	—	$0.04	—	—	$5.4B	—

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$5.4B	$6.2B	$6.6B	$5.5B	$5B	$6.3B	$6.8B	$6B	$5.8B	$5.8B
YoY change	-5.54%	+14.5%	+7.36%	-16.8%	-10.1%	+27.7%	+7.08%	-11.3%	-4.07%	+0.45%

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$1.5B	$1.4B	$1.4B	$1.5B	$1.5B	$1.4B	$1.4B	$1.6B	$1.5B	$1.3B	$1.4B	$1.6B
YoY change	-16.3%	+1.72%	-12.1%	-6.39%	+0.94%	+2.42%	+1.33%	+5.01%	-0.4%	-4.59%	+0.95%	-1.49%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	5.4B	6.2B	6.6B	5.5B	5B	6.3B	6.8B	6B	5.8B	5.8B
Cost of revenue	4.3B	4.4B	4.7B	4.5B	3.9B	5B	5.2B	4.7B	4.6B	4.9B
Gross profit	1.1B	1.7B	2B	1.1B	1.1B	1.4B	1.6B	1.3B	1.2B	902M
Gross margin	20.4%	28.2%	29.7%	19.2%	21.5%	21.8%	23.8%	21.7%	19.9%	15.5%
Research & development	81M	81M	82M	80M	93M	107M	118M	108M	109M	108M
Selling, general & administrative	946M	626M	657M	548M	527M	592M	710M	1.3B	585M	799M
Operating expenses	1B	740M	729M	651M	661M	707M	830M	1.4B	708M	930M
Operating income	76M	1B	1.2B	412M	406M	674M	786M	-123M	443M	-28M
Operating margin	1.41%	16.3%	18.6%	7.46%	8.17%	10.6%	11.6%	-2.04%	7.66%	-0.48%
Non-operating income, net	132M	121M	118M	-328M	-17M	187M	118M	13M	-52M	20M
Pretax income	-11M	912M	1.2B	-124M	179M	676M	741M	-318M	127M	-277M
Income tax	-18M	165M	159M	-72M	-40M	68M	163M	-81M	41M	109M
Net income	7M	747M	996M	-52M	219M	608M	578M	-237M	86M	-386M
Net margin	0.13%	12.1%	15%	-0.94%	4.41%	9.58%	8.51%	-3.93%	1.49%	-6.65%
EBITDA	459M	1.4B	1.7B	451M	788M	1.1B	1.2B	248M	801M	376M
EPS	0.04	4.04	5.62	-0.32	1.33	3.69	3.72	-1.6	0.58	-2.57
Diluted EPS	0.04	3.91	5.45	-0.32	1.32	3.6	3.65	-1.6	0.57	-2.57

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	1.5B	1.4B	1.4B	1.5B	1.5B	1.4B	1.4B	1.6B	1.5B	1.3B	1.4B	1.6B
Cost of revenue	1.2B	1.1B	1.1B	1.2B	1.2B	1.1B	1.1B	1.3B	1.3B	1.2B	1.2B	1.3B
Gross profit	273M	247M	286M	306M	286M	273M	236M	278M	233M	156M	212M	286M
Gross margin	18.4%	18.1%	21.2%	19.9%	19.1%	19.6%	17.3%	17.2%	15.6%	11.7%	15.4%	18%
Research & development	28M	26M	28M	26M	29M	26M	27M	28M	26M	27M	26M	27M
Selling, general & administrative	165M	223M	144M	139M	135M	169M	123M	437M	109M	130M	147M	469M
Operating expenses	216M	255M	176M	165M	166M	198M	158M	465M	140M	161M	173M	496M
Operating income	57M	-8M	110M	141M	120M	75M	78M	-187M	93M	-5M	39M	-210M
Operating margin	3.83%	-0.59%	8.15%	9.17%	7.99%	5.38%	5.7%	-11.6%	6.22%	-0.38%	2.82%	-13.2%
Non-operating income, net	11M	-10M	20M	7M	-81M	1M	-12M	-7M	26M	6M	8M	277M
Pretax income	13M	-81M	67M	82M	-30M	9M	0	-261M	51M	-67M	-22M	-1M
Income tax	1M	-55M	15M	12M	-3M	17M	4M	119M	-9M	-5M	7M	273M
Net income	12M	-26M	52M	70M	-27M	-8M	-4M	-380M	60M	-62M	-29M	-274M
Net margin	0.81%	-1.91%	3.85%	4.55%	-1.8%	-0.57%	-0.29%	-23.5%	4.01%	-4.66%	-2.1%	-17.2%
EBITDA	151M	77M	197M	232M	216M	163M	181M	-80M	191M	91M	147M	-113M
EPS	0.08	—	0.35	0.47	-0.18	—	-0.03	-2.54	0.4	—	-0.19	-1.81
Diluted EPS	0.08	—	0.34	0.46	-0.18	—	-0.03	-2.54	0.4	—	-0.19	-1.81

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	902M	1.6B	1.2B	943M	1.1B	1.5B	1.1B	1.2B	713M	670M
Receivables	742M	847M	790M	602M	449M	644M	509M	509M	619M	562M
Inventory	767M	935M	1.1B	1.1B	939M	1.1B	1.4B	1.4B	1.5B	1.6B
Total current assets	2.6B	3.5B	3.3B	2.8B	2.6B	3.3B	3.2B	3.8B	3B	3B
Property, plant & equipment	8.7B	9.1B	9.7B	10.3B	10.3B	2.2B	2.2B	2.3B	2.3B	2.2B
Goodwill & intangibles	340M	332M	362M	348M	334M	216M	230M	210M	98M	96M
Total assets	6.1B	7.3B	7.4B	7.3B	7.1B	7.5B	7.6B	8.3B	7.5B	7.4B
Accounts payable	858M	1B	1.1B	901M	820M	1.1B	1.2B	1.1B	1.1B	929M
Short-term debt	15M	15M	13M	200M	78M	84M	92M	106M	107M	104M
Total current liabilities	1.8B	1.6B	1.7B	1.5B	1.4B	1.9B	1.9B	2.5B	1.8B	1.7B
Long-term debt	3.5B	4.1B	4B	4.3B	4.2B	3.9B	3.8B	4.2B	4.2B	4.3B
Total liabilities	6B	6.4B	6.3B	6.6B	6.3B	6.5B	6.5B	7.5B	6.9B	7.1B
Shareholders' equity	104M	865M	1B	695M	815M	1.1B	1.1B	739M	605M	251M
Total debt	3.5B	4.1B	4B	4.5B	4.3B	4B	3.9B	4.3B	4.4B	4.4B
Net debt	2.6B	2.6B	2.8B	3.5B	3.2B	2.5B	2.8B	3.1B	3.6B	3.7B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	852M	1.2B	746M	604M	596M	713M	464M	502M	613M	670M	563M	671M
Receivables	753M	509M	692M	788M	825M	619M	704M	813M	817M	562M	645M	773M
Inventory	1.3B	1.4B	1.4B	1.4B	1.4B	1.5B	1.6B	1.6B	1.5B	1.6B	1.5B	1.5B
Total current assets	3.7B	3.8B	3.6B	2.9B	3.1B	3B	2.9B	3.1B	3.2B	3B	2.9B	3.1B
Property, plant & equipment	2.2B	2.3B	2.3B	2.3B	2.3B	2.3B	2.3B	2.2B	2.2B	2.2B	2.1B	2.1B
Goodwill & intangibles	214M	210M	210M	210M	98M	98M	96M	96M	96M	96M	96M	96M
Total assets	7.9B	8.3B	8B	7.2B	7.5B	7.5B	7.4B	7.5B	7.6B	7.4B	7.3B	7.2B
Accounts payable	878M	1.1B	939M	911M	1B	1.1B	978M	995M	1B	929M	863M	907M
Short-term debt	78M	106M	94M	90M	106M	107M	104M	99M	114M	104M	99M	91M
Total current liabilities	2.2B	2.5B	2.2B	1.6B	1.8B	1.8B	1.7B	1.9B	1.9B	1.7B	1.6B	1.9B
Long-term debt	4.2B	4.2B	4.2B	4.1B	4.2B	4.2B	4.3B	4.3B	4.3B	4.3B	4.3B	4B
Total liabilities	7.2B	7.5B	7.2B	6.5B	6.8B	6.9B	6.8B	7.2B	7.3B	7.1B	7.1B	7.2B
Shareholders' equity	757M	739M	754M	725M	659M	605M	580M	239M	300M	251M	216M	-48M
Total debt	4.2B	4.3B	4.3B	4.2B	4.3B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.1B
Net debt	3.4B	3.1B	3.5B	3.6B	3.7B	3.6B	3.9B	3.9B	3.8B	3.7B	3.8B	3.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	7M	747M	996M	-52M	219M	608M	578M	-237M	86M	-386M
Depreciation & amortization	284M	273M	284M	311M	320M	317M	291M	307M	301M	340M
Stock-based compensation	—	29M	24M	19M	16M	34M	27M	18M	15M	21M
Change in working capital	484M	-406M	-173M	138M	356M	21M	-103M	620M	-1.1B	178M
Operating cash flow	866M	716M	1.1B	282M	779M	913M	796M	645M	-692M	264M
Capital expenditure	-338M	-411M	-498M	-481M	-267M	-277M	-307M	-370M	-360M	—
Investing cash flow	357M	-370M	-487M	-483M	-234M	220M	-287M	-221M	-355M	8M
Dividends paid	-22M	-22M	-148M	-164M	-164M	-164M	-154M	-149M	-148M	-78M
Share repurchases	0	-106M	-644M	-322M	0	-173M	-495M	-69M	0	0
Financing cash flow	-407M	321M	-1B	-596M	-887M	-577M	-737M	153M	-45M	-126M
Net change in cash	816M	667M	-349M	-797M	-342M	556M	-228M	577M	-1.1B	146M
Free cash flow	256M	229M	642M	169M	540M	537M	448M	186M	-993M	51M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	11M	-25M	52M	67M	-19M	-8M	-4M	-379M	60M	-62M	-29M	-274M
Depreciation & amortization	76M	74M	71M	74M	78M	78M	88M	92M	79M	81M	79M	80M
Stock-based compensation	6M	5M	1M	6M	5M	3M	5M	7M	5M	4M	7M	7M
Change in working capital	148M	-220M	-388M	-740M	14M	54M	-215M	298M	16M	92M	-82M	358M
Operating cash flow	243M	-200M	-277M	-612M	94M	103M	-104M	93M	146M	137M	-44M	158M
Capital expenditure	-86M	-135M	-102M	-73M	-76M	-109M	-84M	—	—	—	—	—
Investing cash flow	66M	-130M	-99M	-71M	-76M	-109M	-84M	—	7M	0	8M	287M
Dividends paid	-37M	-37M	-37M	-37M	-38M	-36M	-37M	-13M	-13M	-15M	-13M	-13M
Share repurchases	-18M	0	0	0	0	0	—	—	—	—	—	—
Financing cash flow	362M	-8M	-55M	-47M	20M	84M	-57M	-27M	42M	-37M	-21M	-290M
Net change in cash	671M	-338M	-431M	-730M	38M	78M	-245M	66M	195M	100M	-57M	155M
Free cash flow	45M	349M	-392M	-693M	63M	29M	-196M	50M	105M	92M	-93M	114M

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	4B	9.3B	5B	3B	4.1B	5.5B	4.6B	4.7B	2.5B	1.8B	2.1B
Enterprise value	6.7B	11.8B	7.8B	6.5B	7.3B	8.1B	7.4B	7.8B	6.2B	5.5B	5.6B
Shares outstanding	181.6M	184.8M	177M	164.8M	164.7M	164.9M	150M	148.9M	149.5M	150.2M	150.2M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	573.1	12.4	5.01	—	18.6	9.1	7.95	—	29.4	—	67.8
P/S	0.74	1.5	0.75	0.54	0.82	0.87	0.68	0.78	0.44	0.3	0.37
P/B	38.6	10.7	4.9	4.29	5.01	5.12	4.15	6.36	4.18	7.06	-44.5
EV/EBITDA	14.5	8.44	4.64	14.4	9.21	7.48	6.16	31.4	7.7	14.6	11.6
EV/Sales	1.23	1.91	1.17	1.18	1.46	1.27	1.09	1.29	1.07	0.95	0.97
Earnings yield	0.17%	8.07%	19.9%	—	5.36%	11%	12.6%	—	3.4%	—	1.47%
FCF yield	6.38%	2.47%	12.9%	5.67%	13.2%	9.7%	9.75%	3.96%	-39.3%	2.88%	14.3%
PEG	—	—	—	—	—	—	—	—	—	—	-2.36

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	20.4%	28.2%	29.7%	19.2%	21.5%	21.8%	23.8%	21.7%	19.9%	15.5%	18%
Operating margin	1.41%	16.3%	18.6%	7.46%	8.17%	10.6%	11.6%	-2.04%	7.66%	-0.48%	1.13%
Net margin	0.13%	12.1%	15%	-0.94%	4.41%	9.58%	8.51%	-3.93%	1.49%	-6.65%	-5.24%
ROE	6.73%	86.4%	97.6%	-7.48%	26.9%	56.2%	52.2%	-32.1%	14.2%	-153.8%	-319.4%
ROA	0.12%	10.2%	13.5%	-0.72%	3.09%	8.05%	7.57%	-2.87%	1.14%	-5.23%	1.42%
ROIC	2.77%	24.1%	28%	9.76%	10.2%	16.8%	15.8%	-3.21%	7.06%	-0.7%	-2.44%
Return on tangible assets	0.12%	10.7%	14.2%	-0.75%	3.25%	8.29%	7.8%	-2.95%	1.16%	-5.3%	-4.32%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.44	2.12	1.93	1.8	1.83	1.8	1.7	1.54	1.68	1.78	1.66
Quick ratio	1.01	1.55	1.26	1.1	1.17	1.21	0.96	1	0.86	0.85	0.88
Debt / equity	34.1	4.75	3.89	6.43	5.25	3.68	3.5	5.82	7.2	17.5	-0.86
Debt / assets	0.58	0.56	0.54	0.62	0.6	0.53	0.51	0.52	0.58	0.6	0.58
Net debt / EBITDA	5.76	1.83	1.65	7.82	4.03	2.35	2.32	12.5	4.55	9.9	10.9
Interest coverage	0.95	5.26	6.92	0.4	1.85	4.65	5.55	-0.53	1.48	-0.03	0.86
Effective tax rate	0%	18.1%	13.8%	0%	0%	10.1%	22%	0%	32.3%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	29.7	33.4	37.5	33.5	30.2	38.5	45.3	40.5	38.7	38.7	38.5
EPS (basic)	0.04	4.04	5.62	-0.32	1.33	3.69	3.72	-1.6	0.58	-2.57	-2.57
EPS (diluted)	0.04	3.91	5.45	-0.32	1.32	3.6	3.65	-1.6	0.57	-2.57	-2.02
Book value per share	0.57	4.68	5.76	4.22	4.95	6.56	7.38	4.96	4.05	1.67	-0.33
FCF per share	1.41	1.24	3.63	1.03	3.28	3.26	2.99	1.25	-6.64	0.34	1.43
Cash per share	4.97	8.42	6.79	5.72	6.71	8.8	7.34	8.08	4.77	4.46	4.46
Capex per share	1.86	2.22	2.81	2.92	1.62	1.68	2.05	2.48	2.41	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	6.26%	6.65%	7.5%	8.7%	5.37%	4.37%	4.52%	6.14%	6.23%	—	—
Capex / operating cash flow	39%	57.4%	43.4%	170.6%	34.3%	30.3%	38.6%	57.4%	-52%	—	—
Payout ratio	314.3%	2.95%	14.9%	-315.4%	74.9%	27%	26.6%	-62.9%	172.1%	-20.2%	555.6%
Dividend yield	0.55%	0.24%	2.96%	5.5%	4.02%	2.96%	3.35%	3.17%	5.86%	4.4%	2.49%

Yield

2.49%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.088

ex-dividend Aug 14, 2026

Payout ratio

556%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 14, 2026	$0.088
May 15, 2026	$0.088
Feb 27, 2026	$0.088
Nov 14, 2025	$0.088
Aug 15, 2025	$0.088
May 16, 2025	$0.088
Feb 28, 2025	$0.25
Nov 15, 2024	$0.25

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.42	$0.42	0.0%	—	$1.6B	—
Q1 26	-$0.04	$0.05	+225.0%	—	$1.4B	—
Q4 25	$0.02	$0.05	+150.0%	—	$1.3B	—
Q3 25	$0.24	$0.2	-16.7%	—	$1.5B	—
Q2 25	$0.46	$0.58	+26.1%	—	$1.6B	—
Q1 25	$0.2	$0.13	-35.0%	—	$1.4B	—
Q4 24	$0.16	$0.11	-31.3%	—	$1.4B	—
Q3 24	$0.28	$0.4	+42.9%	—	$1.5B	—
Q2 24	$0.58	$0.38	-34.5%	—	$1.5B	—
Q1 24	$0.17	$0.32	+88.2%	—	$1.4B	—
Q4 23	$0.24	$0.31	+29.2%	—	$1.4B	—
Q3 23	$0.69	$0.63	-8.7%	—	$1.5B	—
Q2 23	$1.07	$1.1	+2.8%	—	$1.6B	—
Q1 23	$0.47	$0.98	+108.5%	—	$1.5B	—
Q3 22	$1.04	$1.24	+19.2%	—	$1.8B	—
Q2 22	$1.43	$1.89	+32.2%	—	$1.9B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$2.57	—	—	$5.8B	—
FY24	—	$0.58	—	—	$5.8B	—
FY23	—	-$1.6	—	—	$6B	—
FY22	—	$3.72	—	—	$6.8B	—
FY21	—	$3.69	—	—	$6.3B	—
FY20	—	$1.33	—	—	$5B	—
FY19	—	-$0.32	—	—	$5.5B	—
FY18	—	$5.62	—	—	$6.6B	—
FY17	—	$4.04	—	—	$6.2B	—
FY16	—	$0.04	—	—	$5.4B	—

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$5.4B	$6.2B	$6.6B	$5.5B	$5B	$6.3B	$6.8B	$6B	$5.8B	$5.8B
YoY change	-5.54%	+14.5%	+7.36%	-16.8%	-10.1%	+27.7%	+7.08%	-11.3%	-4.07%	+0.45%

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$1.5B	$1.4B	$1.4B	$1.5B	$1.5B	$1.4B	$1.4B	$1.6B	$1.5B	$1.3B	$1.4B	$1.6B
YoY change	-16.3%	+1.72%	-12.1%	-6.39%	+0.94%	+2.42%	+1.33%	+5.01%	-0.4%	-4.59%	+0.95%	-1.49%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	5.4B	6.2B	6.6B	5.5B	5B	6.3B	6.8B	6B	5.8B	5.8B
Cost of revenue	4.3B	4.4B	4.7B	4.5B	3.9B	5B	5.2B	4.7B	4.6B	4.9B
Gross profit	1.1B	1.7B	2B	1.1B	1.1B	1.4B	1.6B	1.3B	1.2B	902M
Gross margin	20.4%	28.2%	29.7%	19.2%	21.5%	21.8%	23.8%	21.7%	19.9%	15.5%
Research & development	81M	81M	82M	80M	93M	107M	118M	108M	109M	108M
Selling, general & administrative	946M	626M	657M	548M	527M	592M	710M	1.3B	585M	799M
Operating expenses	1B	740M	729M	651M	661M	707M	830M	1.4B	708M	930M
Operating income	76M	1B	1.2B	412M	406M	674M	786M	-123M	443M	-28M
Operating margin	1.41%	16.3%	18.6%	7.46%	8.17%	10.6%	11.6%	-2.04%	7.66%	-0.48%
Non-operating income, net	132M	121M	118M	-328M	-17M	187M	118M	13M	-52M	20M
Pretax income	-11M	912M	1.2B	-124M	179M	676M	741M	-318M	127M	-277M
Income tax	-18M	165M	159M	-72M	-40M	68M	163M	-81M	41M	109M
Net income	7M	747M	996M	-52M	219M	608M	578M	-237M	86M	-386M
Net margin	0.13%	12.1%	15%	-0.94%	4.41%	9.58%	8.51%	-3.93%	1.49%	-6.65%
EBITDA	459M	1.4B	1.7B	451M	788M	1.1B	1.2B	248M	801M	376M
EPS	0.04	4.04	5.62	-0.32	1.33	3.69	3.72	-1.6	0.58	-2.57
Diluted EPS	0.04	3.91	5.45	-0.32	1.32	3.6	3.65	-1.6	0.57	-2.57

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	1.5B	1.4B	1.4B	1.5B	1.5B	1.4B	1.4B	1.6B	1.5B	1.3B	1.4B	1.6B
Cost of revenue	1.2B	1.1B	1.1B	1.2B	1.2B	1.1B	1.1B	1.3B	1.3B	1.2B	1.2B	1.3B
Gross profit	273M	247M	286M	306M	286M	273M	236M	278M	233M	156M	212M	286M
Gross margin	18.4%	18.1%	21.2%	19.9%	19.1%	19.6%	17.3%	17.2%	15.6%	11.7%	15.4%	18%
Research & development	28M	26M	28M	26M	29M	26M	27M	28M	26M	27M	26M	27M
Selling, general & administrative	165M	223M	144M	139M	135M	169M	123M	437M	109M	130M	147M	469M
Operating expenses	216M	255M	176M	165M	166M	198M	158M	465M	140M	161M	173M	496M
Operating income	57M	-8M	110M	141M	120M	75M	78M	-187M	93M	-5M	39M	-210M
Operating margin	3.83%	-0.59%	8.15%	9.17%	7.99%	5.38%	5.7%	-11.6%	6.22%	-0.38%	2.82%	-13.2%
Non-operating income, net	11M	-10M	20M	7M	-81M	1M	-12M	-7M	26M	6M	8M	277M
Pretax income	13M	-81M	67M	82M	-30M	9M	0	-261M	51M	-67M	-22M	-1M
Income tax	1M	-55M	15M	12M	-3M	17M	4M	119M	-9M	-5M	7M	273M
Net income	12M	-26M	52M	70M	-27M	-8M	-4M	-380M	60M	-62M	-29M	-274M
Net margin	0.81%	-1.91%	3.85%	4.55%	-1.8%	-0.57%	-0.29%	-23.5%	4.01%	-4.66%	-2.1%	-17.2%
EBITDA	151M	77M	197M	232M	216M	163M	181M	-80M	191M	91M	147M	-113M
EPS	0.08	—	0.35	0.47	-0.18	—	-0.03	-2.54	0.4	—	-0.19	-1.81
Diluted EPS	0.08	—	0.34	0.46	-0.18	—	-0.03	-2.54	0.4	—	-0.19	-1.81

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	902M	1.6B	1.2B	943M	1.1B	1.5B	1.1B	1.2B	713M	670M
Receivables	742M	847M	790M	602M	449M	644M	509M	509M	619M	562M
Inventory	767M	935M	1.1B	1.1B	939M	1.1B	1.4B	1.4B	1.5B	1.6B
Total current assets	2.6B	3.5B	3.3B	2.8B	2.6B	3.3B	3.2B	3.8B	3B	3B
Property, plant & equipment	8.7B	9.1B	9.7B	10.3B	10.3B	2.2B	2.2B	2.3B	2.3B	2.2B
Goodwill & intangibles	340M	332M	362M	348M	334M	216M	230M	210M	98M	96M
Total assets	6.1B	7.3B	7.4B	7.3B	7.1B	7.5B	7.6B	8.3B	7.5B	7.4B
Accounts payable	858M	1B	1.1B	901M	820M	1.1B	1.2B	1.1B	1.1B	929M
Short-term debt	15M	15M	13M	200M	78M	84M	92M	106M	107M	104M
Total current liabilities	1.8B	1.6B	1.7B	1.5B	1.4B	1.9B	1.9B	2.5B	1.8B	1.7B
Long-term debt	3.5B	4.1B	4B	4.3B	4.2B	3.9B	3.8B	4.2B	4.2B	4.3B
Total liabilities	6B	6.4B	6.3B	6.6B	6.3B	6.5B	6.5B	7.5B	6.9B	7.1B
Shareholders' equity	104M	865M	1B	695M	815M	1.1B	1.1B	739M	605M	251M
Total debt	3.5B	4.1B	4B	4.5B	4.3B	4B	3.9B	4.3B	4.4B	4.4B
Net debt	2.6B	2.6B	2.8B	3.5B	3.2B	2.5B	2.8B	3.1B	3.6B	3.7B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	852M	1.2B	746M	604M	596M	713M	464M	502M	613M	670M	563M	671M
Receivables	753M	509M	692M	788M	825M	619M	704M	813M	817M	562M	645M	773M
Inventory	1.3B	1.4B	1.4B	1.4B	1.4B	1.5B	1.6B	1.6B	1.5B	1.6B	1.5B	1.5B
Total current assets	3.7B	3.8B	3.6B	2.9B	3.1B	3B	2.9B	3.1B	3.2B	3B	2.9B	3.1B
Property, plant & equipment	2.2B	2.3B	2.3B	2.3B	2.3B	2.3B	2.3B	2.2B	2.2B	2.2B	2.1B	2.1B
Goodwill & intangibles	214M	210M	210M	210M	98M	98M	96M	96M	96M	96M	96M	96M
Total assets	7.9B	8.3B	8B	7.2B	7.5B	7.5B	7.4B	7.5B	7.6B	7.4B	7.3B	7.2B
Accounts payable	878M	1.1B	939M	911M	1B	1.1B	978M	995M	1B	929M	863M	907M
Short-term debt	78M	106M	94M	90M	106M	107M	104M	99M	114M	104M	99M	91M
Total current liabilities	2.2B	2.5B	2.2B	1.6B	1.8B	1.8B	1.7B	1.9B	1.9B	1.7B	1.6B	1.9B
Long-term debt	4.2B	4.2B	4.2B	4.1B	4.2B	4.2B	4.3B	4.3B	4.3B	4.3B	4.3B	4B
Total liabilities	7.2B	7.5B	7.2B	6.5B	6.8B	6.9B	6.8B	7.2B	7.3B	7.1B	7.1B	7.2B
Shareholders' equity	757M	739M	754M	725M	659M	605M	580M	239M	300M	251M	216M	-48M
Total debt	4.2B	4.3B	4.3B	4.2B	4.3B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.1B
Net debt	3.4B	3.1B	3.5B	3.6B	3.7B	3.6B	3.9B	3.9B	3.8B	3.7B	3.8B	3.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	7M	747M	996M	-52M	219M	608M	578M	-237M	86M	-386M
Depreciation & amortization	284M	273M	284M	311M	320M	317M	291M	307M	301M	340M
Stock-based compensation	—	29M	24M	19M	16M	34M	27M	18M	15M	21M
Change in working capital	484M	-406M	-173M	138M	356M	21M	-103M	620M	-1.1B	178M
Operating cash flow	866M	716M	1.1B	282M	779M	913M	796M	645M	-692M	264M
Capital expenditure	-338M	-411M	-498M	-481M	-267M	-277M	-307M	-370M	-360M	—
Investing cash flow	357M	-370M	-487M	-483M	-234M	220M	-287M	-221M	-355M	8M
Dividends paid	-22M	-22M	-148M	-164M	-164M	-164M	-154M	-149M	-148M	-78M
Share repurchases	0	-106M	-644M	-322M	0	-173M	-495M	-69M	0	0
Financing cash flow	-407M	321M	-1B	-596M	-887M	-577M	-737M	153M	-45M	-126M
Net change in cash	816M	667M	-349M	-797M	-342M	556M	-228M	577M	-1.1B	146M
Free cash flow	256M	229M	642M	169M	540M	537M	448M	186M	-993M	51M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	11M	-25M	52M	67M	-19M	-8M	-4M	-379M	60M	-62M	-29M	-274M
Depreciation & amortization	76M	74M	71M	74M	78M	78M	88M	92M	79M	81M	79M	80M
Stock-based compensation	6M	5M	1M	6M	5M	3M	5M	7M	5M	4M	7M	7M
Change in working capital	148M	-220M	-388M	-740M	14M	54M	-215M	298M	16M	92M	-82M	358M
Operating cash flow	243M	-200M	-277M	-612M	94M	103M	-104M	93M	146M	137M	-44M	158M
Capital expenditure	-86M	-135M	-102M	-73M	-76M	-109M	-84M	—	—	—	—	—
Investing cash flow	66M	-130M	-99M	-71M	-76M	-109M	-84M	—	7M	0	8M	287M
Dividends paid	-37M	-37M	-37M	-37M	-38M	-36M	-37M	-13M	-13M	-15M	-13M	-13M
Share repurchases	-18M	0	0	0	0	0	—	—	—	—	—	—
Financing cash flow	362M	-8M	-55M	-47M	20M	84M	-57M	-27M	42M	-37M	-21M	-290M
Net change in cash	671M	-338M	-431M	-730M	38M	78M	-245M	66M	195M	100M	-57M	155M
Free cash flow	45M	349M	-392M	-693M	63M	29M	-196M	50M	105M	92M	-93M	114M

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	4B	9.3B	5B	3B	4.1B	5.5B	4.6B	4.7B	2.5B	1.8B	2.1B
Enterprise value	6.7B	11.8B	7.8B	6.5B	7.3B	8.1B	7.4B	7.8B	6.2B	5.5B	5.6B
Shares outstanding	181.6M	184.8M	177M	164.8M	164.7M	164.9M	150M	148.9M	149.5M	150.2M	150.2M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	573.1	12.4	5.01	—	18.6	9.1	7.95	—	29.4	—	67.8
P/S	0.74	1.5	0.75	0.54	0.82	0.87	0.68	0.78	0.44	0.3	0.37
P/B	38.6	10.7	4.9	4.29	5.01	5.12	4.15	6.36	4.18	7.06	-44.5
EV/EBITDA	14.5	8.44	4.64	14.4	9.21	7.48	6.16	31.4	7.7	14.6	11.6
EV/Sales	1.23	1.91	1.17	1.18	1.46	1.27	1.09	1.29	1.07	0.95	0.97
Earnings yield	0.17%	8.07%	19.9%	—	5.36%	11%	12.6%	—	3.4%	—	1.47%
FCF yield	6.38%	2.47%	12.9%	5.67%	13.2%	9.7%	9.75%	3.96%	-39.3%	2.88%	14.3%
PEG	—	—	—	—	—	—	—	—	—	—	-2.36

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	20.4%	28.2%	29.7%	19.2%	21.5%	21.8%	23.8%	21.7%	19.9%	15.5%	18%
Operating margin	1.41%	16.3%	18.6%	7.46%	8.17%	10.6%	11.6%	-2.04%	7.66%	-0.48%	1.13%
Net margin	0.13%	12.1%	15%	-0.94%	4.41%	9.58%	8.51%	-3.93%	1.49%	-6.65%	-5.24%
ROE	6.73%	86.4%	97.6%	-7.48%	26.9%	56.2%	52.2%	-32.1%	14.2%	-153.8%	-319.4%
ROA	0.12%	10.2%	13.5%	-0.72%	3.09%	8.05%	7.57%	-2.87%	1.14%	-5.23%	1.42%
ROIC	2.77%	24.1%	28%	9.76%	10.2%	16.8%	15.8%	-3.21%	7.06%	-0.7%	-2.44%
Return on tangible assets	0.12%	10.7%	14.2%	-0.75%	3.25%	8.29%	7.8%	-2.95%	1.16%	-5.3%	-4.32%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.44	2.12	1.93	1.8	1.83	1.8	1.7	1.54	1.68	1.78	1.66
Quick ratio	1.01	1.55	1.26	1.1	1.17	1.21	0.96	1	0.86	0.85	0.88
Debt / equity	34.1	4.75	3.89	6.43	5.25	3.68	3.5	5.82	7.2	17.5	-0.86
Debt / assets	0.58	0.56	0.54	0.62	0.6	0.53	0.51	0.52	0.58	0.6	0.58
Net debt / EBITDA	5.76	1.83	1.65	7.82	4.03	2.35	2.32	12.5	4.55	9.9	10.9
Interest coverage	0.95	5.26	6.92	0.4	1.85	4.65	5.55	-0.53	1.48	-0.03	0.86
Effective tax rate	0%	18.1%	13.8%	0%	0%	10.1%	22%	0%	32.3%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	29.7	33.4	37.5	33.5	30.2	38.5	45.3	40.5	38.7	38.7	38.5
EPS (basic)	0.04	4.04	5.62	-0.32	1.33	3.69	3.72	-1.6	0.58	-2.57	-2.57
EPS (diluted)	0.04	3.91	5.45	-0.32	1.32	3.6	3.65	-1.6	0.57	-2.57	-2.02
Book value per share	0.57	4.68	5.76	4.22	4.95	6.56	7.38	4.96	4.05	1.67	-0.33
FCF per share	1.41	1.24	3.63	1.03	3.28	3.26	2.99	1.25	-6.64	0.34	1.43
Cash per share	4.97	8.42	6.79	5.72	6.71	8.8	7.34	8.08	4.77	4.46	4.46
Capex per share	1.86	2.22	2.81	2.92	1.62	1.68	2.05	2.48	2.41	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	6.26%	6.65%	7.5%	8.7%	5.37%	4.37%	4.52%	6.14%	6.23%	—	—
Capex / operating cash flow	39%	57.4%	43.4%	170.6%	34.3%	30.3%	38.6%	57.4%	-52%	—	—
Payout ratio	314.3%	2.95%	14.9%	-315.4%	74.9%	27%	26.6%	-62.9%	172.1%	-20.2%	555.6%
Dividend yield	0.55%	0.24%	2.96%	5.5%	4.02%	2.96%	3.35%	3.17%	5.86%	4.4%	2.49%

Yield

2.49%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.088

ex-dividend Aug 14, 2026

Payout ratio

556%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 14, 2026	$0.088
May 15, 2026	$0.088
Feb 27, 2026	$0.088
Nov 14, 2025	$0.088
Aug 15, 2025	$0.088
May 16, 2025	$0.088
Feb 28, 2025	$0.25
Nov 15, 2024	$0.25

The Chemours Company Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

The Chemours Company Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts